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Duchenne muscular dystrophy (DMD) is the most com-
mon childhood muscular dystrophy, affecting 1 in 3500
live male births. Mutations in the X chromosome result
in an absence of dystrophin, causing progressive muscle
degeneration and loss of ambulation by the early teens
with respiratory, orthopaedic and cardiac complications.
Without intervention these complications lead to death
at a mean age of 19 years. However, the natural history of
DMD is well-known and can be changed with proactive
multidisciplinary management to address predictable
complications[1]. Better care has led to a growing adult
DMD population, challenging the notion of DMD as a
“paediatric” disease. This population faces particular
challenges, not only medical (e.g. associated with long-
term steroid usage, orthopaedic, ventilation, and cardiac,
gastrointestinal or genitourinary problems), but those
associated with wider issues of transition. These include
medical transfer from paediatric to adult services, and
social transition to independent living and full societal
inclusion.
Transfer arrangements to adult facilities, which vary
considerably between clinics and countries, are usually
needed due to regulations governing access to paediatric
services. As DMD requires co-ordinated care, this move
from cohesive paediatric clinics to disjointed adult services
is often problematic, and a successful transfer should be
the culmination of a period of planned transition. Wider
social transition, enabling independent living and further
education/employment, is also very important[2]. How-
ever, as with many other disabilities, adults with DMD
face obstacles to full participation. Planning is crucial, and
preparation for adulthood should be considered in
partnership with families as part of a comprehensive pack-
age of psychosocial care from diagnosis.
Recent research suggests that despite legal and health
frameworks, DMD transition care in the UK is highly
diverse and sometimes lacking[3]. Positive experiences
were characterised by forward planning and long-standing
relationships between the family and healthcare profes-
sionals. In Denmark an integrated model of care is pro-
vided by the National Rehabilitation Centre for NMDs
(RCfM), which supports families from diagnosis with a
comprehensive programme of courses and interventions at
significant life milestones[4]. Patient advocacy groups also
play a very important role in transition, particularly
through programmes such as the MDA Transitions Center.
Although there is no one-size-fits-all model for DMD
transition care, some features seem particularly important
to successful transitions. These include continuity and sta-
bility in care; the integration of wider social issues; the
involvement of the young man and his family in decision-
making; and the support of patient advocacy groups.
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